Alpine Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-11-2024
- Paid Up Capital ₹ 2.50 M
as on 15-11-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.96 Cr
as on 15-11-2024
- Revenue -83.36%
(FY 2023)
- Profit -1806.30%
(FY 2023)
- Ebitda -78.93%
(FY 2023)
- Net Worth -15.57%
(FY 2023)
- Total Assets -55.39%
(FY 2023)
About Alpine Superspeciality Hospital
The Corporate was formerly known as Jara Hospitals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹2.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mangesh Rajput, Archana Rajput, and Ravish Rawal serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC296385
- Company No.
296385
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Alpine Superspeciality Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mangesh Rajput  | Director | 21-Jun-2017 | Current |
| Archana Rajput | Director | 21-Jun-2017 | Current |
| Ravish Rawal | Director | 11-May-2023 | Current |
Financial Performance of Alpine Superspeciality Hospital.
Alpine Superspeciality Hospital Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.36% decrease. The company also saw a substantial fall in profitability, with a 1806.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpine Superspeciality Hospital?
In 2023, Alpine Superspeciality Hospital had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Jalgaon Peoples Co-Op Bank Limited Creation Date: 14 Sep 2018 | ₹1.03 Cr | Satisfied |
Others Creation Date: 29 Dec 2017 | ₹1.93 Cr | Satisfied |
How Many Employees Work at Alpine Superspeciality Hospital?
Alpine Superspeciality Hospital has a workforce of 24 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpine Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpine Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
